Order Article Reprints

M. Sieuwerts A, A. Inda M, Smid M, van Ooijen H, van de Stolpe A, Martens JWM, Verhaegh WFJ. ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen. Cancers. 2020; 12(4):802. https://doi.org/10.3390/cancers12040802

M. Sieuwerts, Anieta, Márcia A. Inda, Marcel Smid, Henk van Ooijen, Anja van de Stolpe, John W. M. Martens, and Wim F. J. Verhaegh. 2020. "ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen" Cancers 12, no. 4: 802. https://doi.org/10.3390/cancers12040802

M. Sieuwerts, A., A. Inda, M., Smid, M., van Ooijen, H., van de Stolpe, A., Martens, J. W. M., & Verhaegh, W. F. J. (2020). ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen. Cancers, 12(4), 802. https://doi.org/10.3390/cancers12040802